Hospitals use a lottery to allocate scarce COVID drugs for the immunocompromised

Posted by on January 25, 2022 3:20 pm
Categories: US National Stories

Evusheld is a treatment authorized for prevention of COVID-19 in people who are seriously immunocompromised or who have had serious adverse reactions to COVID-19 vaccines.

So far the government has distributed about 300,000 doses of Evusheld, a new drug that protects against COVID-19. Some 7 million Americans could benefit from the drug right away.

(Image credit: Peter Bostrom/AstraZeneca)

Leave a Reply

Your email address will not be published.